{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:26:07Z","timestamp":1792725967150,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejca.2025.115691","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T20:05:01Z","timestamp":1754424301000},"page":"115691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Hepatic metastases management: A comparative review of surgical resection, thermal ablation, and stereotactic body radiation therapy"],"prefix":"10.1016","volume":"228","author":[{"given":"Paolo","family":"Torielli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"McGale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8130-9848","authenticated-orcid":false,"given":"Matthew J.","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8569-6523","authenticated-orcid":false,"given":"Rami","family":"Rhaiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Botsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1867-0248","authenticated-orcid":false,"given":"Olivier","family":"Gerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1605-9819","authenticated-orcid":false,"given":"Abdallah","family":"Lamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaacov","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Madelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6306-8008","authenticated-orcid":false,"given":"Laura","family":"Rozenblum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abin","family":"Sajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8212-7790","authenticated-orcid":false,"given":"Mickael","family":"Tordjman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Dercle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Beddok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2025.115691_bib1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2015-310912","article-title":"Global patterns and trends in colorectal cancer incidence and mortality","volume":"66","author":"Arnold","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ejca.2025.115691_bib2","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","article-title":"Liver metastases","volume":"7","author":"Tsilimigras","year":"2021","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejca.2025.115691_bib4","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/cam4.2474","article-title":"Are 90% of deaths from cancer caused by metastases?","volume":"8","author":"Dillek\u00e5s","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2025.115691_bib5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(94)92529-1","article-title":"Factors influencing the natural history of colorectal liver metastases","volume":"343","author":"Stangl","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2025.115691_bib6","doi-asserted-by":"crossref","first-page":"djx015","DOI":"10.1093\/jnci\/djx015","article-title":"Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial","volume":"109","author":"Ruers","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2025.115691_bib7","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2025.115691_bib8","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: Long-Term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","article-title":"Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended Long-Term outcomes","volume":"114","author":"Harrow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115691_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.surg.2024.04.015","article-title":"Comparative cost-effectiveness of open, laparoscopic, and robotic liver resection: a systematic review and network meta-analysis","volume":"176","author":"Koh","year":"2024","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.ejca.2025.115691_bib11","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1245\/s10434-020-08549-9","article-title":"ASO author reflections: assessing the outcomes of liver cancer patients undergoing surgery over the last Decade-Are we doing better?","volume":"27","author":"Tsilimigras","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib12","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1245\/ASO.2006.05.039","article-title":"Survival after hepatic resection for colorectal metastases: a 10-year experience","volume":"13","author":"Wei","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib13","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.1099","article-title":"Is cure possible for breast cancer metastatic to the liver?","volume":"40","author":"Adam","year":"2022","journal-title":"JCO"},{"key":"10.1016\/j.ejca.2025.115691_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1159\/000486523","article-title":"Ten-Year survival after liver resection for breast metastases: a Single-Center experience","volume":"35","author":"Ercolani","year":"2018","journal-title":"Dig Surg"},{"key":"10.1016\/j.ejca.2025.115691_bib15","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/SLA.0b013e31818a07f1","article-title":"R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?","volume":"248","author":"de Haas","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2025.115691_bib16","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.7150\/jca.58580","article-title":"Prospective Non-Randomized study of intraoperative assessment of surgical resection margin of Colo-Rectal liver metastases","volume":"12","author":"Protic","year":"2021","journal-title":"J Cancer"},{"key":"10.1016\/j.ejca.2025.115691_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4254\/wjh.v6.i10.745","article-title":"Comprehensive review of post-liver resection surgical complications and a new universal classification and grading system","volume":"6","author":"Ishii","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.ejca.2025.115691_bib18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejso.2020.09.001","article-title":"Post hepatectomy liver failure (PHLF) - recent advances in prevention and clinical management","volume":"47","author":"S\u00f8reide","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib19","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/bjs\/znad233","article-title":"E-AHPBA-ESSO-ESSR innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy","volume":"110","author":"Primavesi","year":"2023","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2025.115691_bib20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.hpb.2015.08.002","article-title":"Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure?","volume":"18","author":"Chapelle","year":"2016","journal-title":"HPB"},{"key":"10.1016\/j.ejca.2025.115691_bib21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1148\/radiol.2016161509","article-title":"Cost-effectiveness of stereotactic body radiation therapy versus radiofrequency ablation for hepatocellular carcinoma: a Markov modeling study","volume":"283","author":"Pollom","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.ejca.2025.115691_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1148\/radiol.2211001624","article-title":"Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients","volume":"221","author":"Solbiati","year":"2001","journal-title":"Radiology"},{"key":"10.1016\/j.ejca.2025.115691_bib23","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.2005.12.039","article-title":"Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study","volume":"23","author":"Berber","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib24","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/01.sla.0000128305.90650.71","article-title":"Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection\/ablation for colorectal liver metastases","volume":"239","author":"Abdalla","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2025.115691_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2023.03.038","article-title":"A prospective multicentre trial on survival after microwave ablation VErsus resection for resectable colorectal liver metastases (MAVERRIC)","volume":"187","author":"Tinguely","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.115691_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jvir.2017.08.021","article-title":"Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control","volume":"29","author":"Shady","year":"2018","journal-title":"J Vasc Inter Radio"},{"key":"10.1016\/j.ejca.2025.115691_bib27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jvir.2017.08.021","article-title":"Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control","volume":"29","author":"Shady","year":"2018","journal-title":"J Vasc Inter Radio"},{"key":"10.1016\/j.ejca.2025.115691_bib28","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ejca.2013.12.008","article-title":"Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the european organisation for research and treatment of cancer #40004 and #40983","volume":"50","author":"Tanis","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.115691_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1051-0443(98)70491-9","article-title":"Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?","volume":"9","author":"Goldberg","year":"1998","journal-title":"J Vasc Inter Radio"},{"key":"10.1016\/j.ejca.2025.115691_bib30","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00268-020-05379-4","article-title":"Microwave thermoablation of colorectal liver metastases close to large hepatic vessels under pringle maneuver minimizes the \u201cHeat sink effect","volume":"44","author":"Rhaiem","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.ejca.2025.115691_bib31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1200\/JCO.2009.23.4450","article-title":"American society of clinical oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer","volume":"28","author":"Wong","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib32","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM task group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.ejca.2025.115691_bib33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American society for therapeutic radiology and oncology (ASTRO) and American college of radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy","volume":"76","author":"Potters","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115691_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.clon.2011.01.155","article-title":"Stereotactic body radiotherapy. Guidelines for commissioners, providers and clinicians: a national report","volume":"23","author":"Kirkbride","year":"2011","journal-title":"Clin Oncol (R Coll Radio)"},{"key":"10.1016\/j.ejca.2025.115691_bib35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clon.2012.04.006","article-title":"The Canadian association of radiation oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy","volume":"24","author":"Sahgal","year":"2012","journal-title":"Clin Oncol (R Coll Radio)"},{"key":"10.1016\/j.ejca.2025.115691_bib36","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2011.07.020","article-title":"Radiotherapy for liver metastases: a review of evidence","volume":"82","author":"H\u00f8yer","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115691_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4329\/wjr.v6.i2.18","article-title":"Treatment of metastatic liver tumors using stereotactic ablative radiotherapy","volume":"6","author":"Nair","year":"2014","journal-title":"World J Radio"},{"key":"10.1016\/j.ejca.2025.115691_bib38","unstructured":"Associazione Italiana di Radioterapia ed Oncologia Clinica. La Radioterapia Stereotassica Nel Trattamento Della Malattia Oligometastatica. Associazione Italiana di Radioterapia ed Oncologia Clinica 2019. https:\/\/www.radioterapiaitalia.it\/linee-guida-raccomandazioni\/raccomandazioni-e-position-paper\/la-radioterapia-stereotassica-nel-trattamento-della-malattia-oligometastatica\/ (Accessed October 29, 2023)."},{"key":"10.1016\/j.ejca.2025.115691_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110240","article-title":"Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer","volume":"195","author":"Franceschini","year":"2024","journal-title":"Radio Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib40","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/02841860600904870","article-title":"Interim analysis of a prospective phase I\/II trial of SBRT for liver metastases","volume":"45","author":"Kavanagh","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib41","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ijrobp.2005.01.002","article-title":"A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases","volume":"62","author":"Schefter","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115691_bib42","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1200\/JCO.2008.20.0600","article-title":"Phase I study of individualized stereotactic body radiotherapy of liver metastases","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib43","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijrobp.2009.08.020","article-title":"Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies","volume":"78","author":"Goodman","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115691_bib44","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib45","first-page":"3381","article-title":"Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results","volume":"29","author":"Ambrosino","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2025.115691_bib46","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ijrobp.2007.08.058","article-title":"Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors","volume":"70","author":"M\u00e9ndez Romero","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115691_bib47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/02841860600904854","article-title":"Phase II study on stereotactic body radiotherapy of colorectal metastases","volume":"45","author":"Hoyer","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib48","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijrobp.2012.12.021","article-title":"Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial","volume":"86","author":"Scorsetti","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115691_bib49","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3109\/02841869509127197","article-title":"Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients","volume":"34","author":"Blomgren","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib50","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ijrobp.2003.08.012","article-title":"Univariate analysis of factors correlated with tumor control probability of three-dimensional conformal hypofractionated high-dose radiotherapy for small pulmonary or hepatic tumors","volume":"58","author":"Wada","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115691_bib51","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/02841860600904821","article-title":"Stereotactic radiotherapy of primary liver cancer and hepatic metastases","volume":"45","author":"Wulf","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib52","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ijrobp.2006.10.025","article-title":"Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases","volume":"67","author":"Katz","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115691_bib53","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/bjs.6895","article-title":"Stereotactic body radiation therapy for colorectal liver metastases","volume":"97","author":"van der Pool","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2025.115691_bib54","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.ijrobp.2020.11.045","article-title":"The Dutch-Belgian registry of stereotactic body radiation therapy for liver metastases: clinical outcomes of 515 patients and 668 metastases","volume":"109","author":"M\u00e9ndez Romero","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115691_bib55","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1007\/s12094-024-03403-w","article-title":"SBRT-SG-01: final results of a prospective multicenter study on stereotactic body radiotherapy for liver metastases","volume":"26","author":"Rodr\u00edguez","year":"2024","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib56","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1148\/rg.220084","article-title":"Imaging features in the liver after stereotactic body radiation therapy","volume":"42","author":"Navin","year":"2022","journal-title":"Radiographics"},{"key":"10.1016\/j.ejca.2025.115691_bib57","first-page":"170","article-title":"Evaluation of response after SBRT for liver tumors","volume":"22","author":"T\u00e9treau","year":"2017","journal-title":"Rep Pr Oncol Radio"},{"key":"10.1016\/j.ejca.2025.115691_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2017.01.013","article-title":"Stereotactic body radiotherapy for oligo-metastatic liver disease - influence of pre-treatment chemotherapy and histology on local tumor control","volume":"123","author":"Klement","year":"2017","journal-title":"Radio Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.radonc.2020.02.008","article-title":"Association of tumor genomic factors and efficacy for metastasis-directed stereotactic body radiotherapy for oligometastatic colorectal cancer","volume":"146","author":"Jethwa","year":"2020","journal-title":"Radio Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib60","article-title":"Stereotactic ablative radiotherapy for oligometastatic disease in liver","volume":"2014","author":"Kim","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ejca.2025.115691_bib61","first-page":"200","article-title":"Radiation hepatitis","volume":"93","author":"Ingold","year":"1965","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1016\/j.ejca.2025.115691_bib62","first-page":"45","article-title":"High versus low dose stereotactic body radiation therapy for hepatic metastases","volume":"20","author":"Kok","year":"2020","journal-title":"ctRO"},{"key":"10.1016\/j.ejca.2025.115691_bib63","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semradonc.2017.02.004","article-title":"Stereotactic body radiotherapy for liver metastases","volume":"27","author":"Goodman","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib64","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1080\/0284186X.2017.1288925","article-title":"Cone beam CT-based set-up strategies with and without rotational correction for stereotactic body radiation therapy in the liver","volume":"56","author":"Bertholet","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib65","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.prro.2015.01.004","article-title":"Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: photons versus protons","volume":"5","author":"Gandhi","year":"2015","journal-title":"Pr Radiat Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1130490","article-title":"Is MRI-Linac helpful in SABR treatments for liver cancer?","volume":"13","author":"Tallet","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib67","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/02841860600904870","article-title":"Interim analysis of a prospective phase I\/II trial of SBRT for liver metastases","volume":"45","author":"Kavanagh","year":"2006","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2025.115691_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2016.06.1098","article-title":"Dosimetric associations with acute liver toxicity in stereotactic body radiation therapy for liver metastases","volume":"96","author":"Barry","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115691_bib69","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00261-016-0687-x","article-title":"Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. Series","volume":"41","author":"Littrup","year":"2016","journal-title":"Abdom Radio (NY)"},{"key":"10.1016\/j.ejca.2025.115691_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107046","article-title":"Irreversible electroporation of hepatocellular carcinoma and colorectal cancer liver metastases: a nationwide multicenter study with short- and long-term follow-up","volume":"49","author":"Fr\u00fchling","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib71","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/ijc.28443","article-title":"Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period","volume":"134","author":"Gruber-Rouh","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2025.115691_bib72","doi-asserted-by":"crossref","DOI":"10.1177\/0300060519892382","article-title":"A retrospective cohort study of low-dose intensity-modulated radiotherapy for unresectable liver metastases","volume":"48","author":"Pei","year":"2020","journal-title":"J Int Med Res"},{"key":"10.1016\/j.ejca.2025.115691_bib73","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.meddos.2010.12.001","article-title":"Dosimetric comparison of RapidArc with fixed gantry intensity-modulated radiotherapy treatment for multiple liver metastases radiotherapy","volume":"36","author":"Yin","year":"2011","journal-title":"Med Dosim"},{"key":"10.1016\/j.ejca.2025.115691_bib74","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.21037\/jgo-20-424","article-title":"Proton stereotactic body radiation therapy for liver metastases-results of 5-year experience for 81 hepatic lesions","volume":"12","author":"Coffman","year":"2021","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib75","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx031","article-title":"Phase II study of Proton-Based stereotactic body radiation therapy for liver metastases: importance of tumor genotype","volume":"109","author":"Hong","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2025.115691_bib76","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.radonc.2022.09.003","article-title":"A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases","volume":"176","author":"Kim","year":"2022","journal-title":"Radio Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib77","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00066-022-02023-z","article-title":"Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer","volume":"199","author":"Yamaguchi","year":"2023","journal-title":"Strahl Onkol"},{"key":"10.1016\/j.ejca.2025.115691_bib78","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1111\/cas.15871","article-title":"Carbon-ion radiotherapy for oligometastatic liver disease: a national multicentric study by the Japan Carbon-Ion radiation oncology study group (J-CROS)","volume":"114","author":"Shiba","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejca.2025.115691_bib79","article-title":"Reirradiation: standards, challenges, and patient-focused strategies across tumor types","author":"Beddok","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2025.115691_bib80","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.18416","article-title":"Clinical response to immunotherapy targeting programmed cell death receptor 1\/Programmed cell death ligand 1 in patients with Treatment-Resistant microsatellite stable colorectal cancer with and without liver metastases","volume":"4","author":"Wang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejca.2025.115691_bib81","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s43018-021-00269-7","article-title":"Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial","volume":"2","author":"Parikh","year":"2021","journal-title":"Nat Cancer"},{"key":"10.1016\/j.ejca.2025.115691_bib82","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221131521","article-title":"Radiotherapy May augment response to immunotherapy in metastatic uveal melanoma patients","volume":"14","author":"Grynberg","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.ejca.2025.115691_bib83","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated t cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat Med"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925004733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925004733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T09:44:36Z","timestamp":1779702276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925004733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":83,"alternative-id":["S0959804925004733"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115691","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic metastases management: A comparative review of surgical resection, thermal ablation, and stereotactic body radiation therapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115691"}}